Hair Repigmentation Associated with the Use of Lenalidomide: Graying May Not Be an Irreversible Process

In 2012, an 81-year-old male patient with multiple myeloma experienced hair repigmentation while being treated with lenalidomide. His completely white hair began to regain its original 'salt-and-pepper' and black color around the sixth week of treatment, with the change persisting even 12 weeks after stopping the medication. This case report suggests that hair graying might be reversible and that lenalidomide's immunomodulatory effects could play a role in this process by possibly influencing cytokine activity and melanocyte function. The findings indicate a potential new avenue for anti-aging and cosmetic treatments, although the exact mechanisms behind lenalidomide-induced hair repigmentation are still unknown and warrant further investigation.